DMD patients show CD45RChigh cells in muscle and CD4+ or CD8+CD45RChigh T cells in blood despite treatment with CS; these cells decreased in the muscle and spleen of CS-treated rats. This evidence concerns the gene CD4 and Duchenne muscular dystrophy.